Drug Profile
JM 1232
Alternative Names: JM-1232(-)Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Maruishi Pharmaceutical
- Class Benzodiazepines; Indoles
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anaesthesia; Anxiety disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Anaesthesia(In volunteers) in Japan
- 16 Jul 2016 No recent reports of development identified for phase-I development in Anxiety-disorders(In volunteers) in Japan
- 19 Nov 2008 Phase-I clinical trials in Anaesthesia in Japan (unspecified route)